Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Journal of Cellular Biochemistry|November 19, 2008
FIAT inhibition increases osteoblast activity by modulating Atf4-dependent functionsVionnie W C Yu, Jad El-Hoss, René St-ArnaudBone|October 4, 2011
JNK inhibitors increase osteogenesis in Nf1-deficient cellsKate Sullivan, Jad El-Hoss, David G Little, et al.Gene|October 8, 2013
Inactivation of the integrin-linked kinase (ILK) in osteoblasts increases mineralizationJad El-Hoss, Alice Arabian, Shoukat Dedhar, et al.Cardiovascular and Interventional Radiology|June 22, 2021
A Budget Impact Model for the use of Drug-Eluting Stents in Patients with Symptomatic Lower-Limb Peripheral Arterial Disease: An Australian PerspectiveNishath Altaf, Thathya Venu Ariyaratne, Adrian Peacock, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2011
A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cellsJad El-Hoss, Kate Sullivan, Tegan Cheng, et al.Oncotarget|August 17, 2016
A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenograftsJad El-Hoss, Duohui Jing, Kathryn Evans, et al.Human Molecular Genetics|October 29, 2013
NF1 is a critical regulator of muscle development and metabolismKate Sullivan, Jad El-Hoss, Kate G R Quinlan, et al.Blood|June 28, 2015
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemiaDonya Moradi Manesh, Jad El-Hoss, Kathryn Evans, et al.Biochemical Pharmacology|January 18, 2014
A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cellsStephen M F Jamieson, Yongchuan Gu, Donya Moradi Manesh, et al.Pageof 1